<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16467,29952">L-Arginine</z:chebi> (&gt; or = 30 mg kg-1, i.v.), but not <z:chebi fb="0" ids="15816">D-arginine</z:chebi> (300 mg kg-1) administered 5 min after unilateral common carotid/middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> increased regional cerebral blood flow (rCBF) within the dorsolateral ischaemic cortex in spontaneously hypertensive rats </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="16467,29952">L-Arginine</z:chebi> (300 mg kg-1) increased rCBF from 22 +/- 2.7 to 33 +/- 4% of baseline as measured by laser-Doppler flowmetry </plain></SENT>
<SENT sid="2" pm="."><plain>This increase may explain the ability of <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> to reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> size following focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>, as reported previously </plain></SENT>
<SENT sid="3" pm="."><plain>The mechanism appears to be mediated by nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> since topical L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (1 microM), a nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase inhibitor, decreased pial arteriole calibre from 115 +/- 2.2 to 106 +/- 0.9% of baseline following <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> infusion (300 mg kg-1) </plain></SENT>
</text></document>